We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Restricting Blood Flow May Prevent ACL Surgery Bone Loss

By HospiMedica International staff writers
Posted on 27 Mar 2019
A new study suggests that combining blood flow restriction (BFR) therapy with traditional rehabilitation may slow bone loss following anterior cruciate ligament (ACL) reconstruction surgery.

Researchers at Houston Methodist Hospital (HMH; Houston, TX, USA) conducted a randomized prospective study that involved 23 physically active patients (mean age 23), who were divided into two groups following ACL reconstruction, BFR and control. More...
While both groups received a similar rehabilitation protocol, during select exercises the BFR group worked out with an 80% arterial limb occlusion applied via an automated tourniquet. Bone mineral density, bone mass, and lean muscle mass were measured using dual-energy X-ray absorptiometry (DEXA).

The results revealed that the addition of BFR therapy to standard rehabilitation exercises prevented muscle mass loss in the whole leg and thigh, when compared to rehabilitation alone. The addition of BFR was also observed to minimize bone mineral content loss, preserving bone density in the treated limb compared to standard rehabilitation alone. The DEXA findings coincided with observed functional outcomes in the BFR group. The study was presented at the American Orthopaedic Society for Sports Medicine/Arthroscopic Association of North America (AOSSM/AANA) specialty day, held during March 2019 in Las Vegas (NV, USA).

“Providing BFR as part of the rehabilitation efforts following ACL surgery appears to help preserve the bone, recover muscle loss, and improve function quicker, “said lead author Bradley Lambert, PhD, of the HMH orthopedic biomechanics research laboratory. “While further research is needed to fully illuminate the physiologic mechanisms responsible, these findings likely have wide ranging implications for fields outside of ACL rehab alone, such as injury prevention, age-related muscle and bone loss, military rehabilitation, and potentially space flight.”

The ACL is a broad, thick collagen band that originates on the anterior portion of the femur in the intercondylar notch and inserts on the posterior aspect of the tibial plateau. The ACL guides the tibia through a normal, stable range of motion, along the end of the femur, maintaining joint stability. The ligament unfortunately is poorly vascularized, and thus has no real ability to heal after a complete tear, leading to further destruction of the articular and meniscal cartilage over time.

Related Links:
Houston Methodist Hospital


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.